SCHEMBL21178426

SCHEMBL21178426

C#Cc1cccc2nc(CCNC(=O)O)n(-c3ccccc3)c(=O)c12

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 7/20 0.48
PIK3CA P42336 6/20 0.48
PIK3CB P42338 6/20 0.48
PIK3CG P48736 6/20 0.48
PDE10A Q9Y233 5/20 0.43
MEN1 O00255 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MAPT P10636 1/20 0.39
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15818372 0.89 PDE10A (0.44) PIK3CDPIK3CBPIK3CGPDE10AMEN1
SCHEMBL21178592 0.89 PIK3CD (0.46) PIK3CDPIK3CAPIK3CBPIK3CGPDE10A
SCHEMBL16584717 0.86 PDE10A (0.53) PIK3CDPDE10AMAPT
SCHEMBL15818242 0.84 PIK3CD (0.55) PIK3CDPIK3CGPDE10AMEN1BLM
SCHEMBL21178484 0.84 PDE10A (0.43) PIK3CDPIK3CAPIK3CBPIK3CGPDE10A
SCHEMBL15818416 0.84 PDE10A (0.45) PIK3CDPIK3CAPIK3CBPIK3CGPDE10A
SCHEMBL15818773 0.84 PDE10A (0.45) PIK3CDPDE10AMEN1BLMKMT2A
SCHEMBL20595317 0.83 PDE10A (0.43) PIK3CDPIK3CBPIK3CGPDE10AMEN1
SCHEMBL21185366 0.83 PIK3CD (0.48) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2
SCHEMBL21178507 0.83 PIK3CD (0.45) PIK3CDPIK3CAPIK3CBPIK3CGPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3740468-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Sunshine Lake Pharma Co., Ltd. (CN) 2020-11-25 EP disclosed
WO-2019143874-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE SUNSHINE LAKE PHARMA CO., LTD. (CN) 2019-07-25 WO disclosed